Followers | 134 |
Posts | 7040 |
Boards Moderated | 0 |
Alias Born | 02/09/2012 |
Tuesday, May 25, 2021 7:07:35 AM
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=163974260
Brilacidin in contrast to Remdesivir ...
HOW MAY WAYS CAN BRILACIDIN "BETTER" REMDESIVIR...FAUCI'S FORCED THERAPEUTIC APPROVAL?
Farrel's post is like "Brilacidin...telling the world":
"How do I love thee?
Let me count the ways!"
REMDESIVIR HAS DEMONSTRATED THAT IT IS INCAPABLE OF SEVERAL BRILACIDIN ANTEDOTES/ACTIONS...which IMO will be observed in Brilacidin C.T.
1. "Brilacidin starts killing Covid 19 in the serum shortly after infusion. It does not require conversion to an active form like Remdesivir and Pfizers PF 07321332." NOWHERE HAS REMDESIVIR DEMONSTRATED THE SAME...
2. Brilacidin..."does not require conversion to an active form like Remdesivir and Pfizers PF 07321332" Both REMDESIVIR and PFIZERS PF 07321332 REQUIRE CONVERSION
3. Brilacidin..."...is the only antiviral being studied which is virucidal. NOWHERE HAS REMDESIVIR, NOR is Pfizers PF 07321332 alleged to DEMONSTRATE THE SAME...
4. "...(RBL) TESTS demonstrated that Brilacidin prevents viral attachment to the cells. NOWHERE HAS REMDESIVIR DEMONSTRATED THE SAME...
5. "Computer simulations showed (BRILACIIN) may deactivate the virus's main protease. " ... NOWHERE HAS REMDESIVIR DEMONSTRATED THE SAME...
6. Brilacidin and its anti-inflammatory properties ...LIMITING (or eliminating? )..Covid 19 inflammatory cascade which leads to many complications including pulmonary failure. NOWHERE HAS REMDESIVIR DEMONSTRATED THE SAME...
7. BRILACIDN..."... (is a) broad spectrum antibiotic may reduce the secondary infection rate in hospitalized patients which has been reported as high as 8%". NEITHER REMDESIVIR nor PFIZERS have ANTIBIOTIC mechanism.
SO WHAT DOES REMDESIVIR (besides many SAE being investigated) DO?
...INDIA and WHO have concluded: NOTHING!
https://www.forbesindia.com/article/global-news/who-rejects-antiviral-drug-remdesivir-as-a-covid19-treatment/64357/1
Even if greater success is demonstrated in Brilacidin's CT with Remdesivir SoC...and FDA requires Brilacidin and Remdesivir to be approved together for EUA, INVESTORS take that Admission of Brilacidin's Efficacy for starters...
It not an IF... at least (see PR) 75% of the patients in the study WILL NOT RECEIVE REMDESIVIR...because 75% of the trial patients will be from RUSSIAN study where Remdesivir was never approved and is NOT SoC...and therefore will not be in either arm.
And to the Question: ..."Can you provide, by way of example, how it could be shown that "Brilacidin is 10% better over Remdesivir"...using the above outcomes?
IMO...its not a question of a "10%" improvement...it is a question of demonstrating any positive outcome related to ANY ONE OF 1-7 above!
Imo ODDS ARE STRONGLY IN THE FAVOR OF BRILACIDIN...for positive results!
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • May 16, 2024 8:13 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM
HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM
Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • INTV • May 15, 2024 10:30 AM
Swifty Global Announces Impressive Financial Results for Q1 2024 • DRCR • May 15, 2024 10:25 AM